Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

● According to Refinitiv, the company's ESG score for its industry is good.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● With a P/E ratio at 85.92 for the current year and 102.41 for next year, earnings multiples are highly attractive compared with competitors.

● With regards to fundamentals, the enterprise value to sales ratio is at 8.91 for the current period. Therefore, the company is undervalued.

● The company has a low valuation given the cash flows generated by its activity.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the past twelve months, EPS forecast has been revised upwards.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.


Weaknesses

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.